Axl kinase inhibitory compounds are disclosed, as well as compositions and methods of using the same in the treatment of cancer and other conditions mediated by and/or associated with Axl kinase.

Edits on 18 Oct, 2023

"update inverses"

Golden AI

edited on 18 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11786602 ASH1L degraders and methods of treatment therewith

Edits on 19 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 19 Sep, 2023

Edits made to:

Infobox (+3 properties)

Infobox

Patent Inventor Names

David J. Bearss0

Hariprasad Vankayalapati0

Yong Xu0

Edits on 23 May, 2023

"Remove leading 0 from patent number"

Golden AI

edited on 23 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 07998966 Axl kinase inhibitors US Patent 7998966 Axl kinase inhibitors

Infobox

Patent Number

07998966

Patent Number

7998966

Edits on 8 Dec, 2021

"Created via: Entity Importer"

Golden AI

created this topic on 8 Dec, 2021

Edits made to:

Infobox (+8 properties)

‌

US Patent 07998966 Axl kinase inhibitors

Infobox

Is a

Patent

Current assignee

‌

SUPERGEN, INC.

Patent jurisdiction

United States Patent and Trademark Office

Patent number

07998966

Date of patent

August 16, 2011

Patent application number

12101591

Date Filed

April 11, 2008

Patent primary examiner

‌

Susanna Moore

Find more entities like US Patent 7998966 Axl kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API